Successful coronary scaffolding achieved with bioabsorbable stents
This article has no abstract so we have provided the first paragraph of the full text.
The benefits of conventional stenting are primarily conferred within weeks of angioplasty, yet the subsequent endurance of the stent can lead to problems such as late stent thrombosis. In the PROGRESS-AMS trial, Erbel and colleagues assessed the feasibility of bioabsorbable coronary stents made from a magnesium alloy—demonstrated in animal pilot studies to be completely absorbed within 2 months.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
